ESC Premium Access

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Presentation

About the speaker

Doctor Mariam Elmegaard Malik

Gentofte University Hospital, Copenhagen (Denmark)
0 follower

3 more presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)

Thumbnail

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Speaker: Mrs M. Fangel (Aalborg, DK)

Thumbnail

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Speaker: Doctor D. Berg (Boston, US)

Thumbnail

Access the full session

The right glucose-lowering drugs for the right patient

Speakers: Doctor M. Malik, Professor A. Norhammar, Mrs M. Fangel, Doctor D. Berg
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

EACVI Premium Access

Heart failure with preserved ejection fraction.

10 December 2021

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

This platform is supported by

logo Novo Nordisk